This is a preview of subscription content, log in via an institution to check access.
Reference
Bae S, et al. Cost-effectiveness analysis of imaging surveillance in stage II and III extremity soft tissue sarcoma: an Australian perspective. Cost Effectiveness and Resource Allocation : 3 Feb 2020. Available from: URL: https://doi.org/10.1186/s12962-020-0202-7
Rights and permissions
About this article
Cite this article
CT optimal surveillance strategy in high-risk soft tissue sarcoma. PharmacoEcon Outcomes News 846, 9 (2020). https://doi.org/10.1007/s40274-020-6548-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6548-4